Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ibex (IBEX) EBT (2022 - 2025)

Ibex (IBEX) has disclosed EBT for 4 consecutive years, with $15.1 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 29.94% to $15.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $53.4 million, a 16.22% increase, with the full-year FY2025 number at $45.9 million, up 12.07% from a year prior.
  • EBT was $15.1 million for Q4 2025 at Ibex, up from $13.5 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $15.1 million in Q4 2025 to a low of $7.3 million in Q4 2023.
  • A 4-year average of $11.1 million and a median of $11.6 million in 2024 define the central range for EBT.
  • Peak YoY movement for EBT: tumbled 34.91% in 2023, then skyrocketed 59.16% in 2024.
  • Ibex's EBT stood at $11.3 million in 2022, then crashed by 34.91% to $7.3 million in 2023, then surged by 58.12% to $11.6 million in 2024, then rose by 29.94% to $15.1 million in 2025.
  • Per Business Quant, the three most recent readings for IBEX's EBT are $15.1 million (Q4 2025), $13.5 million (Q3 2025), and $11.8 million (Q2 2025).